Northrop Grumman Corporation
NOC
$551.80
-1.16%
Northrop Grumman Corporation is a premier global aerospace and defense technology company, providing advanced systems and products across aeronautics, defense, mission, and space segments. It is a top-tier U.S. defense contractor and a market leader in strategic platforms, most notably as the prime contractor for the B-21 Raider stealth bomber and a key supplier for the F-35 program. The current investor narrative is intensely focused on the interplay between massive proposed increases in U.S. defense spending, which could reach Cold War-era levels, and the stock's recent sharp price correction, creating a debate over whether this represents a long-term buying opportunity or reflects deeper concerns about program execution and budget allocation risks.…
NOC
Northrop Grumman Corporation
$551.80
Related headlines
Investment Opinion: Should I buy NOC Today?
Rating & Thesis: The synthesized recommendation is a Buy, based on the thesis that the stock's sharp ~23% pullback from its highs has created an attractive entry point for a fundamentally strong company with visible long-term growth, trading at a reasonable valuation relative to its own history and supported by a bullish analyst consensus.
Supporting Evidence: This Buy rating is supported by four key data points. First, valuation: the forward P/E of 18.8x is below recent historical highs and justified by 9.6% YoY revenue growth. Second, profitability: net margin expanded from 5.08% to 12.18% through FY2025. Third, cash flow: robust TTM FCF of $3.31 billion supports the dividend (1.58% yield) and financial stability. Fourth, analyst targets: the average price target of $701 implies a 23% upside, with 15 analysts largely maintaining Buy ratings.
Risks & Conditions: The two biggest risks are a further delay or reallocation of the proposed defense budget surge, and a breakdown of technical support leading to a test of the $453 low. This Buy rating would downgrade to Hold if the price fails to hold above $550 support or if quarterly revenue growth decelerates below 5%. It would downgrade to Sell if the debt-to-equity ratio rises above 1.5 or if the company issues guidance below the estimated EPS low of $36.60. The stock is currently fairly valued relative to its own recent history but offers value relative to its growth trajectory and analyst targets.
Sign up to view all
NOC 12-Month Price Forecast
The AI assessment is bullish with medium confidence, viewing the severe recent price decline (-18.5% in 1 month) as disproportionate to the company's solid fundamentals and growth visibility. The primary driver is the valuation opportunity created by the sell-off, juxtaposed with the potential for sustained defense budget tailwinds. Confidence is tempered by the stock's broken technical picture and the political dependency of the thesis. The stance would upgrade to high-confidence bullish on a sustained price recovery above the $600 level and concrete progress on budget approvals. It would downgrade to neutral if the stock breaks below the $550 support zone on high volume.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Northrop Grumman Corporation's 12-month outlook, with a consensus price target around $717.34 and implied upside of +30.0% versus the current price.
Average Target
$717.34
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$441 - $717
Analyst target range
The stock is covered by 15 analysts, and the institutional ratings show a strong bullish bias, with recent actions from firms like Citigroup, UBS, and BofA Securities maintaining Buy or equivalent ratings, though one firm (Truist) downgraded from Buy to Hold in January. The consensus recommendation is a Buy, and the average target price implied by the estimated EPS of $37.31 and a forward P/E of 18.8x is approximately $701, representing a potential upside of over 23% from the current price of $568.14, indicating analysts see significant value after the recent pullback. The target range, derived from estimated EPS lows and highs of $36.60 to $38.24, suggests a price range of roughly $688 to $719; the high end assumes flawless execution on major programs and no budget cuts, while the low end likely factors in potential cost overruns or political delays. The relatively tight target spread and the preponderance of recent reaffirmations suggest analyst conviction in the long-term story remains intact despite near-term price volatility.
Bulls vs Bears: NOC Investment Factors
The evidence currently tilts slightly bullish, primarily due to the significant disconnect between the stock's sharp technical decline and the sustained fundamental strength and analyst optimism. The core tension in the investment debate is whether the recent ~23% price correction represents an overreaction to political headline noise and sector rotation, creating a compelling value opportunity, or correctly anticipates future risks to defense budget allocation and program execution that could impair growth and compress the stock's sector premium. The resolution of this tension hinges on the visibility and timing of proposed defense budget increases flowing into NOC's order book.
Bullish
- Strong Analyst Conviction & Upside: Analysts maintain a strong Buy consensus with an average target price of $701, implying a 23% upside from the current price of $568.14. This conviction is based on a forward P/E of 18.8x applied to estimated EPS of $37.31, suggesting the recent sell-off is seen as a buying opportunity.
- Robust Revenue Growth & Backlog Visibility: Q4 2025 revenue grew 9.6% year-over-year to $11.71 billion, with consistent quarterly expansion from Q1. This growth is underpinned by a massive, multi-year backlog from key programs like the B-21 Raider and F-35, providing high earnings visibility amidst proposed defense budget increases.
- Significant Margin Expansion: Net margin expanded from 5.08% in Q1 2025 to 12.18% in Q4 2025, demonstrating operational leverage as revenue scaled. This improvement in profitability, alongside robust TTM free cash flow of $3.31 billion, strengthens the company's financial flexibility for shareholder returns.
- Attractive Valuation Relative to History: The trailing P/E of 19.57x is well below the 38.48x seen in Q1 2025 and below the Q2 2023 level of 21.29x, placing it in the middle-to-lower end of its recent historical band. The recent correction has priced out previous exuberance, offering a more reasonable entry point.
Bearish
- Severe Technical Breakdown & Momentum Loss: The stock has plummeted 18.49% over the past month, underperforming the S&P 500 by 28.47 percentage points, signaling a severe loss of relative strength. It currently trades at 73% of its 52-week range, having declined 17.93% over three months, indicating a pronounced downtrend that may not have fully stabilized.
- Valuation Premium to Industrial Sector: Despite the correction, NOC's trailing P/E of 19.57x still trades at a premium to the typical mid-teens average for the Industrials sector. This premium relies on sustained defense budget growth; any political delays or reallocation of funds could trigger further valuation compression.
- High Dependence on Political Budget Cycles: The investment thesis is heavily reliant on proposed massive defense spending increases, which are subject to political approval and reallocation risks. Recent news highlights potential volatility from political rhetoric (e.g., NATO exit discussions) and budget focus shifts away from NOC's key programs like the B-21.
- Leveraged Balance Sheet: The company operates with a debt-to-equity ratio of 1.18. While manageable given strong cash flows, this leverage increases financial risk in a rising interest rate environment or if program execution issues lead to cash flow pressure.
NOC Technical Analysis
The stock is in a pronounced downtrend from its recent highs, having declined 11.34% year-to-date and 17.93% over the last three months. As of the latest close at $568.14, the price sits at approximately 73% of its 52-week range ($453.01 to $774.00), indicating a significant retreat from its highs and positioning it in the lower-middle portion of its annual band, which suggests the momentum-driven optimism has fully unwound, presenting a potential value entry point if the fundamental thesis holds. Recent momentum is decisively negative and diverging sharply from the still-positive 1-year return of 16.74%; the stock has plummeted 18.49% over the past month, underperforming the S&P 500 by a staggering 28.47 percentage points, signaling a severe breakdown in relative strength and likely driven by profit-taking and sector rotation following its earlier surge. Key technical support is now the 52-week low area near $453, while resistance lies at the recent highs around $774; a sustained break below the $550-$570 consolidation zone could target the $453 low, whereas a recovery above the 50-day moving average would be needed to signal stabilization. The stock's beta of 0.046 is anomalously low and not reflective of its recent volatility, but its maximum drawdown of -26.03% highlights the significant downside risk experienced during this correction.
Beta
-0.11
-0.11x market volatility
Max Drawdown
-28.6%
Largest decline past year
52-Week Range
$453-$774
Price range past year
Annual Return
+17.2%
Cumulative gain past year
| Period | NOC Return | S&P 500 |
|---|---|---|
| 1m | -19.0% | +8.2% |
| 3m | -20.6% | +9.0% |
| 6m | -1.1% | +10.5% |
| 1y | +17.2% | +26.5% |
| ytd | -5.8% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NOC Fundamental Analysis
Revenue growth is solid, with Q4 2025 revenue of $11.71 billion representing a 9.6% year-over-year increase, and the sequential trend from Q1's $9.47 billion shows consistent quarterly expansion, driven by broad-based demand across its defense portfolio. The Aeronautics segment, at $3.92 billion in the latest period, is the largest revenue contributor, supported by key programs like the B-21 and F-35. The company is highly profitable, with Q4 net income of $1.43 billion and a net margin of 12.18%, though gross margin of 19.6% reflects the cost-plus nature of many government contracts; profitability has improved from Q1's net margin of 5.08%, indicating margin expansion through the year as revenue scaled. The balance sheet is leveraged but manageable, with a debt-to-equity ratio of 1.18 and a current ratio of 1.09, indicating adequate short-term liquidity; critically, the company generates robust cash flow, with trailing twelve-month free cash flow of $3.31 billion, providing ample internal funding for dividends, share buybacks, and capital expenditures without excessive reliance on external debt markets.
Quarterly Revenue
$11.7B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.19%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NOC Overvalued?
Given its consistent profitability, the primary valuation metric is the P/E ratio. The trailing P/E is 19.57x, while the forward P/E is 18.80x, indicating the market expects modest earnings growth, with the small compression suggesting stable, not accelerating, near-term prospects. Compared to the Industrials sector, Northrop Grumman's trailing P/E of 19.57x trades at a premium to a typical industrial average (often in the mid-teens), a premium justified by its defensive revenue streams, high visibility via a massive backlog, and the current geopolitical tailwinds supporting defense budgets. Historically, the stock's own trailing P/E has ranged widely; the current 19.57x is below the 21.29x seen in Q2 2023 and well below the 38.48x from Q1 2025, placing it in the middle-to-lower end of its recent historical band, suggesting the recent sell-off has priced out previous exuberance and returned valuations to a more reasonable level relative to its own history.
PE
19.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Northrop Grumman's financial risks are moderated by its strong cash generation, with TTM FCF of $3.31 billion covering its debt service and shareholder returns. However, operational risks center on program execution for complex, fixed-price contracts like the B-21, where cost overruns could pressure the improved 12.18% net margin. Revenue, while diversified, has significant concentration in the Aeronautics segment ($3.92B in Q4), making it sensitive to the timing and funding of major aircraft programs. The debt-to-equity ratio of 1.18 indicates a leveraged balance sheet, though the current ratio of 1.09 suggests adequate short-term liquidity.
Market & Competitive Risks: The primary market risk is valuation compression. Despite its recent drop, NOC's P/E of 19.57x remains at a premium to the broader industrials sector, making it vulnerable to multiple contraction if growth expectations moderate. The stock's recent -26.03% maximum drawdown and severe underperformance versus the S&P 500 highlight its sensitivity to sector rotation and political headlines regarding defense spending. Competitive risks include potential budget reallocation to other defense priorities (e.g., missile defense, shipbuilding) as suggested by recent news, which could disadvantage NOC's flagship bomber program.
Worst-Case Scenario: The worst-case scenario involves a combination of political gridlock delaying or reducing proposed defense budget increases, coupled with technical execution issues on the B-21 program leading to cost overruns and margin pressure. This could trigger analyst downgrades, a derating of the P/E multiple towards the industrial sector average, and a flight from the stock. A realistic downside target would be a retest of the 52-week low of $453.01, which would represent a loss of approximately -20% from the current price of $568.14. A more severe bear case, incorporating a broader market downturn, could see losses extend towards -30%.
FAQ
The key risks are, in order of severity: 1) Political/Budget Risk: The investment thesis is highly dependent on proposed defense spending increases, which are subject to approval, delay, and reallocation. 2) Technical/Momentum Risk: The stock is in a severe downtrend, down 18.5% in one month, and a break below $550 support could trigger further selling. 3) Execution Risk: Complex programs like the B-21 are prone to cost overruns, which could pressure the improved 12.18% net margin. 4) Valuation Risk: The P/E of 19.57x remains at a sector premium, making it vulnerable to multiple compression if growth slows.
The 12-month forecast presents three scenarios. The Base Case (55% probability) targets $688-$701, assuming steady execution and delayed but eventual budget increases. The Bull Case (30% probability) targets $719-$774, driven by swift budget approval and flawless program execution. The Bear Case (15% probability) targets $453-$550, triggered by budget gridlock and technical breakdown. The most likely scenario is the Base Case, anchored by the analyst average target of $701, which assumes the company meets its estimated EPS of $37.31 and political headwinds eventually subside.
NOC is fairly valued relative to its own recent history but may be slightly undervalued relative to its growth trajectory and analyst targets. Its trailing P/E of 19.57x trades at a premium to the broader Industrials sector, which is justified by its defensive revenue and high backlog visibility. However, this multiple is well below its Q1 2025 peak of 38.48x and is in the middle-to-lower end of its recent historical band. The forward P/E of 18.8x implies the market expects stable, modest earnings growth. The ~23% upside to analyst targets suggests the market may be undervaluing the company's earnings power post-sell-off.
For investors with a long-term horizon and tolerance for political and headline volatility, NOC represents a good buying opportunity following its sharp correction. The stock offers a 23% upside to the analyst average target of $701, is supported by 9.6% revenue growth and expanding margins, and trades at a more reasonable valuation relative to its own history. The key downside risk is a retest of the $453 low (-20% from here) if defense budget optimism fades. It is a good buy for those who believe the long-term defense spending thesis remains intact and can look past near-term technical weakness.
NOC is primarily suitable for long-term investment (3-5 year horizon). Its value proposition is tied to multi-year defense budget cycles and the decade-long production run of programs like the B-21, not short-term trading catalysts. The stock's low beta (0.046) is not reflective of its recent volatility but suggests lower correlation to the broad market over time, and its 1.58% dividend yield supports a total return approach. Given the current technical weakness and political overhang, short-term trading is risky. A minimum holding period of 12-18 months is suggested to allow for the investment thesis around budget approvals to play out.